SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Izzy who wrote (5029)7/31/1998 11:21:00 AM
From: Oliver & Co   of 6136
 
From Microsoft Investor today:

Advisor
ÿ

Top alerts for Agouron Pharmaceuticals, Inc.
On 7/30/98: It was reported that the current quarter mean earnings estimate for AGPH increased. Learn More. See Earnings Estimates See Consensus EPS Trend

From 7/29/98 to 7/30/98: The three-month relative price strength rating for AGPH was at least 20 percentage points above its 12 month relative strength. Learn More. See a Historical Chart

On 7/22/98: It was reported that AGPH fell short of average analysts earnings estimates. Learn More. See Earnings Surprise

On 4/14/98: It was reported that AGPH beat average analyst earnings estimates. Learn More. See Earnings Surprise

Research alerts for Agouron Pharmaceuticals, Inc.
On 7/22/98: Analysis of the latest financial results for AGPH showed that the company's profit margin increased for at least the fifth year in a row. Learn More. See Ten Year Summary

Since 6/26/98: Analysis shows that the price-to-sales ratio (PSR) of AGPH has been at least 25% above its Industry's average. A PSR significantly above the industry average suggests that a stock may be fully valued or overvalued. Learn More. See Price Ratios

Since 5/4/98: Analysis showed that the price-to-cash-flow ratio of AGPH has been at least 25% above its industry average. Learn More. See Price Ratios



Top

Terms of Use, and Privacy Policy. c 1996-98 Microsoft Corporation and/or its suppliers. All rights reserved.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext